Structural validation and immunogenic characterization of Streptococcus pneumoniae serotype 22A capsular polysaccharide relative to serotype 22F

Key Points

• Structural validation confirms the architecture of serotype 22A capsular polysaccharide.
• Immunogenic characterization reveals distinct immune responses for serotypes 22A and 22F.
• Comparative analysis highlights differences that may influence vaccine effectiveness.
• Further studies may enhance understanding of capsular polysaccharide variations.